Bupropion
Showing 51 - 75 of 567
MDD, Treatment Resistant Depression Trial in New York (AXS-05, Bupropion SR)
Enrolling by invitation
- Major Depressive Disorder
- Treatment Resistant Depression
- AXS-05
- Bupropion SR
-
New York, New YorkAxsome Research Site
Jul 20, 2021
Cigarette Smoking-Related Carcinoma Trial in Houston (Bupropion Hydrochloride Controlled-release, Nicotine Replacement,
Unknown status
- Cigarette Smoking-Related Carcinoma
- Bupropion Hydrochloride Controlled-release
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2020
Nicotine Dependence, Nicotine Withdrawal Trial in Minneapolis (Bupropion, Varenicline)
Completed
- Nicotine Dependence
- Nicotine Withdrawal
- Bupropion
- Varenicline
-
Minneapolis, MinnesotaUniversity of Minnesota, Tobacco Use Research Center
Oct 30, 2020
Smoking Cessation, Cancer, Treatment-Related Trial in Lexington (drug, behavioral, other)
Recruiting
- Smoking Cessation
- Cancer, Treatment-Related
- Varenicline
- +6 more
-
Lexington, KentuckyUniversity Of Kentucky, Markey Cancer Center
Feb 9, 2022
Wilson Disease Trial in Austin (ALXN1840, Bupropion Hydrochloride)
Completed
- Wilson Disease
- ALXN1840
- Bupropion Hydrochloride
-
Austin, TexasClinical Trial Site
Jul 21, 2021
Type 2 Diabetes, Obesity Trial in Cleveland (Weight Management Program (WMP), Traditional care, Phentermine / Topiramate
Recruiting
- Type 2 Diabetes
- Obesity
- Weight Management Program (WMP)
- +5 more
-
Cleveland, OhioCleveland Clinic
Jan 28, 2022
Healthy Volunteers Trial in Barcelona (Bupropion, Anastrozole, Testosterone cyclopentylpropionate)
Completed
- Healthy Volunteers
- Bupropion
- +4 more
-
Barcelona, SpainIMIM (Hospital del Mar Medical Research Institute)
Apr 23, 2021
MDD Trial in United States (AXS-05, Bupropion)
Tobacco Use Disorder, Smoking Cessation Trial in Houston (Bupropion, Varenicline, Placebo)
Completed
- Tobacco Use Disorder
- Smoking Cessation
- Bupropion
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 7, 2021
Mitochondrial Disease Trial in Leeds (KL1333, Flurbiprofen, Dextromethorphan)
Completed
- Mitochondrial Disease
- KL1333
- +7 more
-
Leeds, United KingdomVolunteer recruitment center Covance Leeds Covance Leeds
Oct 19, 2021
Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)
Recruiting
- Depression
- +6 more
- Good Days Ahead (GDA)
- +3 more
-
Indianapolis, IndianaIUPUI Department of Psychology
Jan 18, 2022
Tuberculosis, Pulmonary Trial in Karachi (Bupropion, Behavioural Change Communication)
Completed
- Tuberculosis, Pulmonary
- Bupropion
- Behavioural Change Communication
-
Karachi, Sindh, PakistanDow University of Health Sciences
Apr 13, 2021
Methamphetamine Use Disorder Trial in United States (Naltrexone: Vivitrol®, Placebo (PLB) Injectable, Bupropion: Wellbutrin XL®)
Completed
- Methamphetamine Use Disorder
- Naltrexone: Vivitrol®
- +3 more
-
Los Angeles, California
- +7 more
Apr 6, 2021
Alcohol Abuse Trial in Chapel Hill (Bupropion, Placebo Oral Tablet)
Completed
- Alcohol Abuse
- Bupropion
- Placebo Oral Tablet
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Aug 24, 2020
Acute Coronary Syndrome, Depressive Symptoms Trial in United States (Cognitive Behavioral Therapy (CBT), Antidepressant
Completed
- Acute Coronary Syndrome
- Depressive Symptoms
- Cognitive Behavioral Therapy (CBT)
- +4 more
-
Bloomington, Minnesota
- +3 more
Nov 10, 2021
Smoking Cessation, Smoking, Tobacco, Smoking (Tobacco) Addiction Trial in Los Angeles (Bupropion HCl extended release)
Not yet recruiting
- Smoking Cessation
- +4 more
- Bupropion hydrochloride extended release
-
Los Angeles, CaliforniaUniversity of Southern California
May 18, 2020
Smoking Cessation, Alcohol Drinking Trial in Durham (other, drug, behavioral)
Completed
- Smoking Cessation
- Alcohol Drinking
- Nicotine Replacement Therapy
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Apr 1, 2021
MDD Trial in Saint Louis (Bupropion XL 300)
Completed
- Major Depressive Disorder
- Bupropion XL 300
-
Saint Louis, MissouriWashington University School of Medicine
Apr 23, 2020
Alcohol Drinking, Depression, Smoking Cessation Trial in Boston (Trial Withdrawn 1, Trial Withdrawn 2)
Withdrawn
- Alcohol Drinking
- +3 more
- Trial Withdrawn 1
- Trial Withdrawn 2
-
Boston, MassachusettsTufts University School of Medicine
Nov 6, 2020
Obesity, Blood Pressure Trial in Athens (Liraglutide 6 MG/ML [Saxenda], Naltrexone-Bupropion Combination)
Recruiting
- Obesity
- Blood Pressure
- Liraglutide 6 MG/ML [Saxenda]
- Naltrexone-Bupropion Combination
-
Athens, GreeceFirst Department of Propaedeutic Internal Medicine
Oct 6, 2020
Obesity Trial in Canada (Contrave 8Mg-90Mg Extended-Release Tablet, Placebo)
Not yet recruiting
- Obesity
- Contrave 8Mg-90Mg Extended-Release Tablet
- Placebo
-
Guelph, Ontario, Canada
- +3 more
Oct 13, 2020
Obesity Trial in Canada (Contrave 8Mg-90Mg Extended-Release Tablet, Placebo)
Unknown status
- Obesity
- Contrave 8Mg-90Mg Extended-Release Tablet
- Placebo
-
Guelph, Ontario, Canada
- +3 more
Oct 9, 2020